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ever, was responsible for an annual attrition rate of the
dAVF ranging from 12% to 27%.6 This study was initiated
to assess the potential for using a relatively inexpensive
animal model to study the hemodynamic and morpho-
logic changes associated with creating a fistula at the dis-
tal anastomosis of a bypass graft.
MATERIAL AND METHODS
Aortofemoral bypass grafts were constructed in 36
male Sprague-Dawley rats with the autologous tail artery.
Microvascular technique with minimal tissue handling was
used in performing the end-to-side anastomosis. Animals
were randomly assigned to the experimental group (n =
18), in which a dAVF was performed, and to the control
group (n = 18), in which the graft was sutured end to side
only to the femoral artery (Fig 1). Hemodynamic, mor-
phologic, and histologic assessments were performed 6
weeks after the bypass surgery. Animal care complied with
the Principles of Laboratory Animal Care, formulated by
the National Society for Medical Research, and the Guide
The maintenance of distal lower extremity perfusion in
the face of restricted runoff continues to be a major chal-
lenge to vascular surgeons dealing with limb-threatening
obliterative atherosclerosis. Adjunctive procedures to
enhance prosthetic and occasionally autogenous graft
patency include anticoagulation, vein patches and cuffs,
and creation of a distal arteriovenous fistula (dAVF).1-6
We have previously demonstrated the impressive augmen-
tation of flow in bypass grafts constructed to crural arter-
ies and associated improved graft patency and limb salvage
rates.7 The development of intimal hyperplasia (IH), how-
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Purpose: The purpose of this study was to evaluate the effects of a distal arteriovenous fistula (dAVF) on the morpho-
logic changes occurring in arterial bypass grafts by the use of a novel experimental model. 
Methods: Aortofemoral bypass grafts with or without dAVFs were constructed in 36 Sprague-Dawley rats with a micro-
surgical technique. The bypass graft material consisted of deendothelialized autogenous tail artery (length, 25 mm;
inside diameter, 0.5 mm). In 18 rats, dAVFs were constructed at the distal anastomosis. After 6 weeks, flow rates and
shear stress were determined, and grafts were then harvested. Luminal, intimal, and medial cross-sectional areas were
measured with computer imaging. Desmin, α–smooth muscle actin, and von Willebrand factor (vWF) were identified
with immunohistochemistry. Endothelialization was evaluated with SEM.
Results: All bypass grafts remained patent at the time of graft harvest. Grafts with dAVFs showed increased flow rates
(11.5 ± 0.6 mL/min) compared with grafts without dAVFs (2.1 ± 0.3 mL/min; P < .01). Shear stress was also
increased in the dAVF group (340.9 ± 23.4 dyne/cm2 vs 113.7 ± 12.5 dyne/cm2; P < .01), with a corresponding sup-
pression of intimal hyperplasia (0.059 ± 0.011 mm2 for dAVF grafts vs 0.225 ± 0.009 mm2 for non-dAVF grafts; P <
.01). Staining for vWF was found in both the reendothelialized flow surface and the neointimal extracellular matrix.
Remodeling of the grafts was characterized by a 50% increased luminal area, 70% decreased intimal area, and a 25%
decreased medial area when a dAVF was constructed. 
Conclusion: A small animal experimental model of an arterial bypass graft can enable the evaluation of a variety of fac-
tors that influence graft patency. Increased blood flow velocity and shear stress induced by a dAVF are associated with
a decrease in intimal and medial areas, which may reflect changes in cell proliferation, apoptosis, migration, or matrix
deposition. Deposition of vWF was also found both in the endothelium and throughout the hyperplastic intima. These
findings suggest that the hemodynamic and morphologic changes associated with dAVF may potentiate graft patency
and function. (J Vasc Surg 2001;34:701-6.)
for the Care and Use of Laboratory Animals, issued by the
National Institutes of Health (US Department of Health
and Human Services, National Institutes of Health publi-
cation no. 80-23, revised 1985).
Bypass model. Anesthesia was induced and main-
tained with intraperitoneal sodium pentobarbital (40
mg/kg). The animals were not anticoagulated during
operations. Surgery was performed with an operating
microscope that had 20 to 40 magnifications. The tail
artery was harvested to a uniform length of 25 mm
through a ventral longitudinal incision. The external
diameter was 0.8 mm. For a hyperplastic response to be
achieved in this vessel, deendothelialization was per-
formed by passing a 0.035-in diameter guidewire (Boston
Scientific Co, Watertown, Mass) three times through the
artery just before harvest. We had previously shown this to
be a reliable method to effect deendothelialization. The
artery was then briefly stored in heparinized Ringer’s lac-
tate solution at room temperature, while dissection of the
aorta and femoral vessels was carried out. The femoral
anastomosis was performed first. In the experimental
group a dAVF was constructed by the use of the common
ostium technique in which a 2-mm longitudinal femoral
arteriotomy and venotomy were followed by a suturing of
the adjacent walls with interrupted monofilament 10-0
nylon sutures (Microsurgery Instruments, Inc, Bellaire,
Tex). The spatulated cut end of the tail artery graft was
then anastomosed to the ostium with the use of similar
interrupted sutures. In the control group the distal anas-
tomosis was constructed with a 2-mm arteriotomy of the
femoral artery alone. The femoral artery proximal to the
distal anastomosis was ligated to ensure flow through the
bypass graft. The proximal anastomosis was then per-
formed end to side to the infrarenal aorta by means of a 2-
mm aortotomy. Throughout the operative procedure, care
was taken to minimize manipulation of the graft. Graft
patency was confirmed intraoperatively with a flowmeter
(Small Animal Flowmeter T206; Transonic Systems Inc,
Ithaca, NY). The average time for the procedure was 2
hours for the control group and 3.5 hours for the experi-
mental group. Rats surviving the procedure with immedi-
ate bypass patency were the basis for this study.
Hemodynamic studies. After 6 weeks of observa-
tion, we explored the animals while they were under
sodium pentobarbital anesthesia before sacrifice. The
bypass graft was inspected and flow rates were measured at
multiple sites along the graft with an ultrasonic flow probe
(0.5VB probe; Transonic Systems, Inc, Ithaca, NY)
designed for small (1 mm) diameter vessels. The direction
and volume of mean blood flow was recorded over a 10-
minute period to permit flow stabilization. Shear stress
was calculated with the modified Hagen-Poiseuille equa-
tion: T = 4ηQ/πr3, where T is shear stress, η is blood vis-
cosity, Q is flow rate in milliliters per second, and r is
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Fig 1. Diagram of rat model aortofemoral bypass graft. A, Bypass
graft without dAVF. B, Bypass graft with dAVF.
Fig 2. Bar graphs for flow rates (A) and shear stress (B) through
normal tail artery and grafts with and without dAVF. Values are
expressed as mean ± SEM.
A
B
radius in centimeters. Blood viscosity (0.035 poise) was
assumed to be constant. The internal radius was deter-
mined by measuring the histologic cross-sectional areas
and adjusting for 30% shrinkage due to the fixation
process.
Graft harvest and processing. After completion of
the blood flow measurements, a perfusion cannula was
placed through the left ventricle into the ascending aorta;
the right atrium was incised for drainage. The rats were
exsanguinated and flushed in situ with a constant-pressure
perfusion system at 120 mm Hg with phosphate-buffered
saline (approximately 500 mL) until the washout was
clear. The vasculature was then perfusion fixed with 2.5%
glutaraldehyde (approximately 250 mL). The midthird
segment of each grafted tail artery was removed and then
immersed in the glutaraldehyde fixative for an additional
24 hours. The specimens were then processed in an auto-
mated tissue processing system (Tissue-TEK; Miles
Scientific, Naperville, Ind) and embedded in paraffin.
Sequential, 5-µm-thick cross sections were cut from each
paraffin-embedded segment. The specimens were then
stained with hematoxylin-eosin and Verhoeff ’s elastin
stain. Segments of tail arteries not used for the bypass pro-
cedure served as the controls for morphometry.
Immunohistochemistry. Representative sections from
each specimen were studied by means of immunohisto-
chemical stains with primary antibodies to α–smooth mus-
cle (SM) actin (monoclonal mouse antihuman antibody,
DAKO Corp, Carpinteria, Calif), desmin (monoclonal
mouse antihuman antibody, DAKO), and von Willebrand
factor (vWF) (polyclonal rabbit antihuman antibody,
DAKO). These antibodies are known to have an interspecies
cross-reactivity with antigens from the rat. Immunohisto-
chemistry was performed as follows: formalin-fixed paraffin
sections (5 µm thick) were cut and air-dried on poly-
L-lysine–coated slides (Histology Control Systems Inc,
Glen Head, NY). After deparaffinization and rehydration,
tissue sections were digested with a Proteinase K solution
(DAKO) to unmask some fixated antigenic sites. The
specimens were then incubated with 3% hydrogen perox-
ide to block endogenous peroxidase and reduce nonspe-
cific binding. Primary antibodies were incubated with the
specimens for 30 minutes at room temperature.
Subsequently, the slides were covered with biotinylated
antimouse secondary antibody to link primary and sec-
ondary antibodies, and incubated with streptavidin perox-
idase to form avidin-biotin complexes. Prepared AEC and
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DAB substrate-chromogen solutions were applied to cover
specimens to result in red and brown end products.
Sections were counterstained with hematoxylin. Specimens
were mounted and coverslipped with a glycerol-mounting
medium. In the control slides, incubation of the primary
antibody was omitted; all other steps were identical.
Morphometry. A digital imaging system consisting
of a microscope attached to a video camera and then
linked to a computer installed with the SAMBO 4000 Cell
Imaging Analysis System software (IPE Imaging Products
International, Inc, Chantilly, Va) was set up to digitize and
then quantitatively analyze the histologic specimens.
Cross-sectional areas of the lumen, intima, and media of
the midgraft were measured (in square millimeter) in three
sections per specimen selected at random. Luminal area
was determined by tracing the inside edge of the vessel
wall and quantifying the area enclosed by the tracing.
Intimal area was defined as the area encompassed by the
internal elastic lamina minus the lumen area. The media
was identified by the immunohistochemical staining of
cells containing SM actin. The outer margin of the media
was defined by the interface between the circular SM cells
of the media and the connective tissue of the adventitia.
Each defined cross-sectional area was manually traced with
the software package. 
Scanning electron microscopy. Endothelial cell cov-
erage at the time of harvest was evaluated with scanning
electron microscopy and compared with cell coverage at
the time of implantation. Portions of the midgraft speci-
mens were sequentially, glutaraldehyde-fixed; rinsed with
phosphate-buffered saline solution; dehydrated in increas-
ing concentrations of ethanol; transferred to acetone; 
and critical-point dried with carbon dioxide. The speci-
mens were then mounted and sputter coated with gold-
palladium. All specimens were examined with a Philips
EM201 scanning electron microscope (Philips Labora-
tories, Eindhoven, The Netherlands).
Statistical analysis. All data are presented as the mean
± the SEM for each group. Comparisons of all groups were
analyzed by means of the analysis of variance, and P values
less than .05 were considered statistically significant.
RESULTS
All animals surviving the operation (n = 36) were main-
tained until graft harvest at 6 weeks. During this interval,
no deaths occurred, and there was no evidence of disability
or lesions in the limbs. At the time of graft harvest, the
Table I. Flow rate measurements and shear stress calculations in the midportion of bypass grafts at the time of harvest
Normal tail arteries Grafts without dAVF Grafts with dAVF 
Hemodynamics (n = 36) (n = 18) (n = 18)
Flow rate (mL/min) 0.2 ± 0.02 2.1 ± 0.3 11.5 ± 0.6*
Shear stress (dyne/cm2) 20 ± 3.0 113.7 ± 12.5 340.9 ± 23.4*
Values are expressed as mean ± SEM. 
*P < .01 versus grafts without dAVF.
patency was 100%. Fourteen other animals were excluded
from this study on the basis of anesthetic death (7), surgical
bleeding (4), and immediate graft thrombosis (3).
Hemodynamics. Blood flow through the in situ tail
artery before harvest was 0.2 ± 0.02 mL/min. Femoral
artery flow in the normal limb was 1.0 ± 0.015 mL/min.
At 6 weeks after bypass surgery, blood flow through grafts
without dAVF was 2.1 ± 0.3 mL/min. Flow through
grafts with dAVF was 11.5 ± 0.6 mL/min fivefold greater
than without dAVF (P < .01, Table I, Fig 2, A). Shear
stress in the in situ tail artery was 20 ± 3 dyne/cm2. There
was a dramatic increase in shear stress after placing the tail
artery into the femoral circulation. Grafts with dAVF had
a threefold greater increase in shear stress (340.9 ± 23.4
dyne/cm2) compared with grafts without dAVF (113.7 ±
12.5 dyne/cm2, P < .01, Table II, Fig 2, B).
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Fig 4. Representative light micrographs of longitudinal section
of midgraft at 6 weeks (hematoxylin and eosin staining). A, Graft
without dAVF. B, Graft with dAVF. Note different thicknesses of
intima and media between these two grafts. I, intima; M, media.
(Original magnification, ×100).
Fig 5. Representative scanning electron micrographs of luminal
surface of midgraft. A, Subendothelial tissue exposed to blood
elements immediately after endothelial stripping just before
implantation. Several residual endothelial cells (arrow) are noted.
B, All grafts were covered by continuous layer of endothelial cells
(arrow) 6 weeks after implantation. Scale bar, 50 µm. (Original
magnification, ×800)
Fig 3. Schematic illustrations and cross-sectional micrographs
(Verhoff’s staining) of middle portion of grafted tail artery at 6
weeks. A, Normal tail artery. B, Graft without dAVF. C, Graft
with dAVF. Arrows indicate outside edges of intimal areas
enclosed by dark-stained internal elastic lamina. Arrowheads point
to interface between media and the adventitia. L, Lumen; dark
area, intima; gray area, media. (Original magnification, ×40).
Graft morphometry. At harvest, the graft luminal
cross-sectional area with dAVF (0.269 ±0.030 mm2) or
without (0.180 ± 0.031 mm2) was significantly larger than
the luminal area of the tail artery before grafting (0.087 ±
0.005 mm2, P < .01, Table II, Figs 3 and 4). After 6 weeks
of implantation, the intimal area was significantly greater
in grafts without dAVF (0.225 ± 0.009 mm2) than in
grafts with dAVF (0.059 ± 0.011 mm2, P < .01). The area
of the media in the native tail artery was 0.143 ± 0.012
mm2. Medial hypertrophy occurred in all grafts, but was
significantly greater in grafts without dAVF (0.440 ±
0.053 mm2) than in those with dAVF (0.326 ± 0.017
mm2, P < .05).
Graft morphology. Six weeks after the deendothe-
lializing injury, the luminal surfaces of all the midgraft
specimens from both groups were covered with a contin-
uous layer of endothelial cells in all animals, as shown in
Fig 5. The myointimal cell, identified by actin and desmin
staining, dominated the cellular component of the IH (Fig
6). An interesting finding was the positive staining for
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vWF in the extracellular matrix of the neointima. This was
also noted in the reendothelialized flow surface and the
vasa vasorum in the adventitia (Fig 7).
DISCUSSION
The IH process, described in detail by several investi-
gators,8-11 consists primarily of SM cell migration and, in
the subintimal position, conversion of these cells to a
secretory function with extracellular matrix deposition.
Factors affecting this process include pressure, flow
dynamics, and mural tension. IH tends to develop at sites
of low wall shear stress and is reduced where shear stress is
high.12 Zarins et al13 showed, in an experimental model in
which arteriovenous fistulas were created in the iliac ves-
sels of monkeys, that increased blood flow results in arte-
rial dilation and normalization of wall shear stress. Arterial
lumen diameter may thus be regulated by shear stress, an
adaptive response to maintain and restore initial lumen
diameter. In this study, a relatively inexpensive model was
created in which a bypass graft was established and the
Fig 6. Representative light micrographs with immunohistochem-
istry staining for α-SM actin (A) and desmin (B) in grafts with
dAVF. Cells in intima and media stained yellow-brown for desmin
and red for α-SM actin. Arrows indicate border between intima
and media (Original magnification, ×100).
Fig 7. Representative light micrographs with immunohisto-
chemistry stains for vWF in grafts without a dAVF. Note presence
of vWF (red) on endothelial layer, in hyperplastic intimal area
(arrow), and on surface of vasa vasorum in adventitia (arrow-
heads). (Original magnification, ×40 and 200).
Table. II. Midgraft cross-sectional area measurements 
Normal tail arteries Grafts without dAVF Grafts with dAVF
Cross section (mm2) (n = 36) (n = 18) (n = 18)
Lumen 0.087 ± 0.005 0.180 ± 0.031 0.269 ± 0.030*
Intima NA 0.225 ± 0.009 0.059 ± 0.011†
Media 0.143 ± 0.012 0.440 ± 0.053 0.326 ± 0.017*
Intimal/medial ratio NA 0.338 ± 0.021 0.153 ± 0.008*
Values are expressed as mean ± SEM.
*P < .05 versus grafts without dAVF.
†P < .01 versus grafts without dAVF.
NA, Not applicable.
impact of a dAVF evaluated with respect to flow dynamics,
morphometry, and morphology. Flow rates increased five
times and shear stress three times in the dAVF group com-
pared with the non-dAVF animals. Luminal area was
altered so that with a dAVF, there was a 50% increase com-
pared with the non-dAVF state. Intimal area decreased by
approximately 70% and medial thickness by 25% in the
comparison of dAVF with non-dAVF animals (Table II,
Figs 3 and 4).
The observation of increased vWF with increasing IH
in the non-dAVF animals is intriguing and suggests a role
for factor VIII in establishing a procoagulatant state when
shear stress is reduced and luminal area is decreased as it
becomes encroached upon by a thickened intimal layer.
This experiment does not address the problem of IH at
anastomotic areas, the site most relevant to clinical states.
The information obtained from our midgraft studies will,
however, form the basis to translate this to anastomotic
studies in the future.
The theoretical basis for using dAVFs as adjuncts to
crural reconstruction to maintain graft patency and distal
perfusion is based on the need to reduce the vascular over-
load being presented to the distal circuit and at the same
time to keep graft flow over the critical thrombotic thresh-
old level.14 Establishing such a vent (dAVF) results in an
increased flow in the graft, most of which is then directed
into the high-capacitance venous circulation. The amount
of blood that can be accepted by the arterial runoff, albeit
limited, will perfuse distally and reverse the ischemic state.
In the clinical setting, we have been impressed by the min-
imal increment of blood required to effect this change.
Intraoperative flow studies have demonstrated a trebling
of graft flow with an adequate dAVF. The predominant
flow is through the fistula, but distal arterial flows of less
than 60 mL/min have been maintained and resulted in
limb salvage. The blood flow changes noted in this exper-
iment simulate the clinical state and enable us to study the
impact of various factors on the blood vessel wall and the
endothelium. The relationship of shear stress to the devel-
opment or reduction of IH has been documented, and
this study confirms the impact of a dAVF on shear stress
and, consequently, the IH process. The modulation of
endothelial cell function by shear stress includes gene reg-
ulation and coding for vasoactive substances, growth fac-
tors, adhesion molecules, chemoattractants, coagulation
factors, and proto-oncogenes.15-17 Examples include the
ability of genes to encode for platelet-derived growth fac-
tor, nitric oxide synthase, monocytochemotactic protein-
1, and the intercellular adhesion molecule-1. We speculate
that similar factors may be operative in our rat model and
need to be defined in future studies. Decreased IH associ-
ated with higher flow rates and increased production of
nitric oxide may contribute to this effect. In this model the
use of the dAVF was studied with respect to its impact on
autogenous artery. Clearly, this will differ from the clinical
situation where the dAVF is generally constructed with a
prosthetic graft that generally does not respond to shear
stress with the graft diameter being unable to change to
any significant degree. Nevertheless, many of the observed
changes, if translatable to the anastomotic graft site, may
aid in understanding the effect of the dAVF in clinical sit-
uations.
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